Congenital Heart Disease News and Research

RSS

Usage of shunts to direct blood flow to lungs can help kids born with hypoplastic left heart syndrome

A trial on shunts used to direct blood flow to the lungs, led by researchers at the University of Michigan's C.S. Mott Children's Hospital, will lead to better outcomes for kids worldwide born with hypoplastic left heart syndrome, the most common severe heart birth defect.

27 May 2010

Largest clinical trial to compare surgical treatments for congenital heart disease

Pediatric researchers report that a recently introduced surgical procedure offers infants with severely underdeveloped hearts a better chance at surviving during their first year of life, in comparison to the standard surgery.

27 May 2010

Infants born with complex congenital heart disease also at risk for life-threatening gastrointestinal diseases

Infants born with complex congenital heart disease are not only at risk for serious heart-related complications, but also for developing a deadly bowel disease, regardless of the type of surgical intervention they receive for their heart. These are the findings from a study by Nationwide Children's Hospital, and appearing in Pediatric Critical Care Medicine published online May 6 ahead of print.

27 May 2010

Researchers discover genetic variant that raises risk of CHD

Although congenital heart disease represents the most common major birth defect, scientists have not previously identified the common variation in the genes that give rise to it. Now genetics and cardiology researchers, two of them brothers, have discovered a genetic variant on chromosome 5 that strongly raises the risk of congenital heart disease.

27 May 2010

New study may lead to better outcomes for kids born with hypoplastic left heart syndrome

27 May 2010

Research sheds light on early embryogenesis, genetic disease

Chromosome 22q11 deletion syndrome (also known as DiGeorge syndrome) is the most common human chromosome deletion syndrome, having an estimated incidence of at least one in 4,000 live births.

15 May 2010

Stereotaxis to be featured prominently in 31st HRS

Stereotaxis' safety and efficacy in the treatment of patients with complex arrhythmias such as atrial fibrillation, ventricular tachycardia, and congenital heart defects will be featured prominently in the scientific program of the 31st Annual Heart Rhythm Scientific Sessions in Denver, Colorado. Eight podium presentations and eight posters will underscore the broad clinical leadership that Stereotaxis has achieved in the treatment of patients with complex cardiac arrhythmias.

13 May 2010

Novel clinical research approaches for rapidly identifying and preventing congenital cardiovascular defects

Structural and functional congenital cardiovascular abnormalities present at birth are the leading source of all congenital defects encountered in live births. Nearly half a million children in the United States have structural heart problems ranging in severity from relatively simple issues, such as small holes between chambers of the heart, to very severe malformations, including complete absence of one or more chambers or valves.

24 Apr 2010

Researchers to measure children with Down syndrome to develop new growth charts

Parents and doctors have known for a long time that children with Down syndrome tend to grow more slowly and are considerably shorter than most other children. But pediatricians needing to record growth milestones at regular office visits have an outdated set of growth charts based on data collected more than 25 years ago.

23 Apr 2010

$SBUMC adds Toshiba Aquilion ONE \320-detector row CT system with pediatric imaging capabilities$

SBUMC adds Toshiba Aquilion ONE \320-detector row CT system with pediatric imaging capabilities

A new state-of-the art computed tomography (CT) scanner that provides physicians with precise images of internal organs with a single rotation of the gantry is now in operation at Stony Brook University Medical Center (SBUMC), adding to the hospital's advanced scanner technology.

15 Apr 2010

PhRMA report: 234 medicines in development for special health care needs of children

America's pharmaceutical research and biotechnology companies are developing 234 medicines for the special health care needs of children, according to a new report released today by the Pharmaceutical Research and Manufacturers of America.

31 Mar 2010

Robertson Foundation commits $10.2M for Duke Medicine's cell therapy research

A $10.2 million commitment from the Robertson Foundation to create a state-of-the-art Translational Cell Therapy Center (TCTC) will advance Duke Medicine's pioneering cell therapy research and treatment programs for children and adults with cancer, cerebral palsy, stroke and brain injuries suffered at birth.

19 Mar 2010

Bench to Bassinet Program aims to move lab results into clinical practice

To help speed the translation of scientific discoveries into usable treatments in congenital heart disease, the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health launched the Bench to Bassinet Program.

17 Mar 2010

10th Annual Spring Meeting of ESC on Cardiovascular Nursing and Allied Professionals

Geneva, situated at the heart of Europe, provides a fitting setting for the 10th Annual Spring Meeting of the European Society of Cardiology Council (ESC) on Cardiovascular Nursing and Allied Professionals (CCNAP), 12 - 13 March 2010, with its special theme: "Uniting to Improve Cardiovascular Practice".

11 Feb 2010

Cardiology 2010 conference focuses on current treatments for children with heart disease

An international group of over 900 medical experts gathers today to discuss the most current treatments for children with heart disease. Affecting about 8 in every 1,000 children, congenital (present at birth) heart disease is the most common birth defect. In its severe forms, it is also the leading cause of death from birth defects in infants.

10 Feb 2010

Study shows cooling technique in heart operations does not impair neurological outcomes in children

Congenital heart defects (CHD) are the most common birth defects in humans, affecting 8 per 1000 live births with one third of affected children requiring intervention in early infancy.

28 Jan 2010

VentriPoint Diagnostics to present abstract on VMS clinical validation study

VentriPoint Diagnostics Ltd. today announced the abstract of a clinical validation study of the second application of the VentriPoint Medical System (VMS) will be presented at the American College of Cardiology's 59th Annual Scientific Session, March 14 to 16 in Atlanta, Georgia. The study demonstrates the accuracy of the method used by the VentriPoint Medical System (VMS) to generate critical heart measurements in three dimensions from two-dimensional ultrasound images with significantly greater speed and accuracy and at considerably lesser cost than is otherwise possible.

27 Jan 2010

Selective use of DHCA during surgery for CHD in infancy does not impair neurological outcomes

Congenital heart defects (CHD) are the most common birth defects in humans, affecting 8 per 1000 live births with one third of affected children requiring intervention in early infancy. Increasing numbers of survivors combined with developmental expectations for independence, behavioral self-regulation and academic achievement have led to a growing identification of neurobehavioral symptoms in some survivors. A study now suggests that a cooling technique often used in heart operations does not impair neurological outcomes.

27 Jan 2010

Medtronic' Melody Transcatheter Pulmonary Valve receives FDA approval under HDE

In a significant development for congenital heart disease patients, Medtronic, Inc. (NYSE: MDT), announced today that its Melody® Transcatheter Pulmonary Valve has received U.S. Food and Drug Administration (FDA) approval under a Humanitarian Device Exemption (HDE).

27 Jan 2010

First Hybrid Cath Lab in Louisiana at Tulane Hospital for Children

The Pediatric Heart Center at Tulane Hospital for Children has opened the first and only Hybrid Cath Lab in Louisiana. The cutting-edge facility -- one of only 10 in the country -- is a fully equipped pediatric catheterization lab and operating room that allows both cardiologists and surgeons to work side by side to open the chest, place delivery catheters in the heart and deploy devices. Outcomes are improved by avoiding cardiopulmonary bypass and shortened procedure times.

23 Jan 2010

Congenital Heart Disease News and Research

Usage of shunts to direct blood flow to lungs can help kids born with hypoplastic left heart syndrome

Largest clinical trial to compare surgical treatments for congenital heart disease

Infants born with complex congenital heart disease also at risk for life-threatening gastrointestinal diseases

Researchers discover genetic variant that raises risk of CHD

New study may lead to better outcomes for kids born with hypoplastic left heart syndrome

Research sheds light on early embryogenesis, genetic disease

Stereotaxis to be featured prominently in 31st HRS

Novel clinical research approaches for rapidly identifying and preventing congenital cardiovascular defects

Researchers to measure children with Down syndrome to develop new growth charts

SBUMC adds Toshiba Aquilion ONE \320-detector row CT system with pediatric imaging capabilities

PhRMA report: 234 medicines in development for special health care needs of children

Robertson Foundation commits $10.2M for Duke Medicine's cell therapy research

Bench to Bassinet Program aims to move lab results into clinical practice

10th Annual Spring Meeting of ESC on Cardiovascular Nursing and Allied Professionals

Cardiology 2010 conference focuses on current treatments for children with heart disease

Study shows cooling technique in heart operations does not impair neurological outcomes in children

VentriPoint Diagnostics to present abstract on VMS clinical validation study

Selective use of DHCA during surgery for CHD in infancy does not impair neurological outcomes

Medtronic' Melody Transcatheter Pulmonary Valve receives FDA approval under HDE

First Hybrid Cath Lab in Louisiana at Tulane Hospital for Children

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News